Cost‐effectiveness of granulocyte colony‐stimulating factor prophylaxis in chemotherapy‐induced febrile neutropenia among breast cancer and Non‐hodgkin's lymphoma patients under Taiwan's national health insurance system

DOI: 10.1111/jep.12597

,

Issn Print: 1356-1294

Publication Date: 2017/04/01

Cost‐effectiveness of granulocyte colony‐stimulating factor prophylaxis in chemotherapy‐induced febrile neutropenia among breast cancer and Non‐Hodgkin's lymphoma patients under Taiwan's national health insurance system

Tsun‐Jen Wen; Yu‐Wen Wen; Chun‐Ru Chien; Shao‐Chin Chiang; William Wei‐Yuan Hsu; Li‐Jiuan Shen; Fei‐Yuan Hsiao

Author Information: Graduate Institute of Clinical Pharmacy, College of Medicine


		Checking for direct PDF access through Ovid

View on Journal Site

Abstract unavailable for this article.


		Loading Related Articles